Search All Tech Briefings

Search technology briefings produced by NIHR Innovation Observatory. These are short reports on new or repurposed medicines that we have already sent to our stakeholders. Only those technologies (medicines) that are within the scope of our stakeholders will have a technology briefing available.  Search our technology briefings by intervention (drug or device), specific indication (disease or condition), or general therapeutic area.

| 72 Results

Intervention Indication Therapeutic Area Year Actions
Baricitinib for treatment of severe alopecia areata in adults Baricitinib (LY3009104; Olumiant) Alopecia areata Dermatology , Immunology 2021 View  |  Download
Baricitinib for systemic lupus erythematosus Baricitinib (LY3009104; Olumiant) Systemic lupus erythematosus (SLE) Immunology , Nephrology 2021 View  |  Download
Avatrombopag in addition to standard of care for chronic immune thrombocytopenia Avatrombopag (Doptelet; E5501; avatrombopag maleate) Immune thrombocytopenia (ITP) Haematology , Immunology 2020 View  |  Download
Avapritinib for advanced systemic mastocytosis Avapritinib (BLU-285; Ayvakit) Systemic mastocytosis Immunology 2020 View  |  Download
Avacopan in addition to standard of care for ANCA-associated vasculitis Avacopan (CCX168) Anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV) Cardiovascular System , Immunology 2018 View  |  Download
AR101 peanut allergy immunotherapy for adult and paediatric patients Palforzia (AR101) Peanut allergy Immunology 2017 View  |  Download
AR101 for peanut allergy in children aged 1 – 3 years Palforzia (AR101) Peanut allergy Immunology 2022 View  |  Download
Anifrolumab for moderately to severly active, autoantibody-positive systemic lupus erythematosus Anifrolumab (MEDI546) Systemic lupus erythematosus (SLE) Immunology , Nephrology 2020 View  |  Download
Alpha-1 antitrypsin for treating high risk, acute graft versus host disease in people aged ≥ 12 years Alpha-1 antitrypsin Graft versus host disease (GvHD) Immunology 2024 View  |  Download
Acarizax for treating allergic rhinitis or allergic rhinoconjunctivitis in children aged 5 to 11 years old Acarizax Allergic rhinitis , Allergic rhinoconjunctivitis Immunology , Ophthalmology 2024 View  |  Download
Medicine Industry's Gateway to NICE
Support for Industry
Outputs & Publications